Cost-Effectiveness of Adjunctive Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Secondary Analysis of EMBOLISE

20260 citationsJournal Articlehybrid Open Access

Authors

Matthew C. Findlay · Cornell University

Gurpreet S. Gandhoke · Cornell University

Jason M. Davies · Cornell University

Jared Knopman · Cornell University

Kenneth J. Smith · Cornell University

Maxim Mokin · Cornell University

Ameer E. Hassan ·

Abstract

At 2024 pricing, and from a U.S. hospital perspective, ES/MMAE for cSDH may not be cost-effective within a 180-day horizon, but PSA suggests a greater favorability towards ES/MMAE at higher willingness-to-pay thresholds. The positive net QALY benefit with adjunctive MMAE for cSDH suggests a small but meaningful quality-of-life improvement, preventing complete ES dominance. Cost-reduction strategies, longer time frames, and validated cSDH-specific patient-reported outcome measures could enhance ES/MMAE cost-effectiveness. These findings could guide future optimization efforts for ES/MMAE for cSDH management.

Topics & Keywords

Neurosurgical Procedures and Complications Intracerebral and Subarachnoid Hemorrhage Research Traumatic Brain Injury and Neurovascular Disturbances

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Neuroradiology

DOI: 10.3174/ajnr.a9319

Field-Weighted Citation Impact: 0.00